Skip to main content
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1975 Feb;19(2):301–308.

A quantitative evaluation of anticoagulants in experimental nephrotoxic nephritis.

N M Thomson, I J Simpson, D K Peters
PMCID: PMC1538088  PMID: 1212801

Abstract

The protective effects of anticoagulants in nephrotoxic nephritis in rabbits have been studied, using various doses of heparin and defibrination with ancrod. Massive doses of heparin (2000 units/kg/day) were required before significant reduction in glomerular fibrin deposition, extracepillary cell proliferation and urea retention occurred. Doses of 300 and 1000 units/kg/day were insufficient to modify fibrin deposition and cell proliferation. Defibrination with ancrod provided protection, judged by histological and functional criteria, comparable to 2000 units of heparin/kg/day; but fibrin could still be demonstrated in the glomeruli of animals treated with 2000 units of heparin/kg/day, contrasting with the virtual absence of fibrin in animals given ancrod.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arieff A. I., Pinggera W. F. Rapidly progressive glomerulonephritis treated with anticoagulants. Arch Intern Med. 1972 Jan;129(1):77–84. [PubMed] [Google Scholar]
  2. HALPERN B., MILLIEZ P., LAGRUE G., FRAY A., MORARD J. C. PROTECTIVE ACTION OF HEPARIN IN EXPERIMENTAL IMMUNE NEPHRITIS. Nature. 1965 Jan 16;205:257–259. doi: 10.1038/205257a0. [DOI] [PubMed] [Google Scholar]
  3. KLEINERMAN J. Effects of heparin on experimental nephritis in rabbits. Lab Invest. 1954 Nov-Dec;3(6):495–508. [PubMed] [Google Scholar]
  4. Kincaid-Smith P., Saker B. M., Fairley K. F. Anticoagulants in "irreversible" acute renal failure. Lancet. 1968 Dec 28;2(7583):1360–1363. doi: 10.1016/s0140-6736(68)92671-8. [DOI] [PubMed] [Google Scholar]
  5. Mancini G., Carbonara A. O., Heremans J. F. Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry. 1965 Sep;2(3):235–254. doi: 10.1016/0019-2791(65)90004-2. [DOI] [PubMed] [Google Scholar]
  6. Naish P., Penn G. B., Evans D. J., Peters D. K. The effect of defibrination on nephrotoxic serum nephritis in rabbits. Clin Sci. 1972 May;42(5):643–646. doi: 10.1042/cs0420643. [DOI] [PubMed] [Google Scholar]
  7. REID H. A., CHAN K. E., THEAN P. C. Prolonged coagulation defect (defibrination syndrome) in Malayan viper bite. Lancet. 1963 Mar 23;1(7282):621–626. doi: 10.1016/s0140-6736(63)91269-8. [DOI] [PubMed] [Google Scholar]
  8. VASSALLI P., MCCLUSKEY R. T. THE PATHOGENIC ROLE OF THE COAGULATION PROCESS IN RABBIT MASUGI NEPHRITIS. Am J Pathol. 1964 Oct;45:653–677. [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES